Pfizer (PFE -0.3%) receives EU approval to broaden the use of its Prevenar 13 drug for...

|About: Pfizer Inc. (PFE)|By:, SA News Editor

Pfizer (PFE -0.3%) receives EU approval to broaden the use of its Prevenar 13 drug for Pneumococcal Disease (PD) to children aged 6-17 from infants and young children. PD is an infection that can cause pneumonia, an infection of the blood, middle-ear infection and bacterial meningitis. (PR)